SCHEMBL5148161

SCHEMBL5148161

CC(=O)NC(=O)Nc1ccc(-n2c3c(c4ccccc42)C(=O)CCC3)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.41
CREBBP Q92793 1/20 0.41
S1PR1 P21453 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
LMNA P02545 1/20 0.37
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
GRM4 Q14833 1/20 0.37
OPRM1 P35372 1/20 0.36
MAOB P27338 1/20 0.36
KDM4E B2RXH2 1/20 0.36
RECQL P46063 1/20 0.36
BRD4 O60885 1/20 0.36
MAPT P10636 2/20 0.35
TSHR P16473 1/20 0.35
BAZ2B Q9UIF8 1/20 0.35
RAB9A P51151 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147134 0.92 LMNA (0.45) TP53CREBBPHDAC1HDAC6LMNA
SCHEMBL5145428 0.88 DOT1L (0.45) TP53CREBBPS1PR1HDAC1HDAC6
SCHEMBL5147135 0.86 HDAC1 (0.43) TP53CREBBPHDAC1HDAC6LMNA
SCHEMBL5147107 0.85 CYP2D6 (0.48) HDAC1HDAC6LMNAMAPTTSHR
SCHEMBL5147078 0.77 HDAC1 (0.48) TP53CREBBPHDAC1HDAC6LMNA
SCHEMBL5148480 0.77 PTGS1 (0.44) HDAC1HDAC6LMNAPTGS1PTGS2
SCHEMBL14422443 0.76 TP53 (0.41) TP53CREBBPHDAC1HDAC6LMNA
SCHEMBL4771960 0.76 CYP3A4 (0.43) TP53CREBBPHDAC1HDAC6PTGS1
SCHEMBL5145359 0.74 GRM4 (0.35) TP53LMNAGRM4MAOBKDM4E
SCHEMBL5145355 0.74 GRM4 (0.35) TP53LMNAGRM4MAOBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US claimed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
WO-2007035620-A2 CARBAZOLE DERIVATIVES SERENEX, INC. (US) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185184-A1 Carbazole derivatives CCNI, MKI67, CCNB3 TP53 111/4885CREBBP 2874/4885S1PR1 858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.